Target-specific immunoPET Imaging of Breast Cancer

Clinical trial NCT06715826 · RECRUITING

Trial details

NCT number: NCT06715826
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasms Breast Cancer Metastatic

Start date: 2024-09-21
Primary completion: 2026-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.